Equillium Reports Fourth Quarter and Full-Year 2018 Financial Results and Recent Highlights LA JOLLA, Calif., March 27, 2019 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology company leveraging deep understanding of immunobiology to develop products to treat severe...

Equillium Announces Plan to Develop EQ001 for the Treatment of Lupus Nephritis Clinical trial evaluating EQ001 for the treatment of refractory lupus nephritis to commence in 2H 2019 Ongoing EQ001 development programs in acute graft-versus-host disease and severe asthma remain...

Autoimmune Disease Diagnostics Market size worth USD 15 Billion by 2023: Global Market Insights Inc. Ocean View, Delaware, July 13, 2016 (GLOBE NEWSWIRE) -- Autoimmune Disease Diagnostics Market size is estimated to reach USD 15.7 billion by 2023; as per a new research report by Global Market...

S.L.E. Lupus Foundation Community-Based Program Provides Model for Patient Support NEW YORK, Sept. 5, 2012 (GLOBE NEWSWIRE) -- A new paper in a special volume of the academic journal Social Work in Health Care highlights the S.L.E. Lupus Foundation as a model for how community-based...